Yes, Depakote (divalproex sodium) is FDA-approved to treat several types of seizures. It’s one of the most widely prescribed antiepileptic medications and has been in use for decades. It works both as a standalone treatment and alongside other seizure medications, depending on the type and severity of epilepsy.
Which Seizure Types Depakote Treats
Depakote is approved for three main uses in epilepsy. First, it treats complex partial seizures, which are episodes that start in one area of the brain and affect awareness. It can be used alone or added to another medication for this type. Second, it treats both simple and complex absence seizures, the brief “staring spells” that are especially common in children. Third, it’s approved as an add-on therapy for people who have multiple seizure types that include absence seizures.
This breadth makes Depakote unusual among seizure medications. Many antiepileptic drugs work well for one or two seizure types, but Depakote covers a wider range, which is why doctors often reach for it when someone has mixed or hard-to-classify epilepsy.
How It Prevents Seizures
Depakote doesn’t appear to work through a single mechanism. Instead, it affects the brain in several ways at once. It boosts levels of GABA, a calming chemical that reduces nerve cell firing. It also appears to block certain sodium and calcium channels in nerve cells, which helps stop the rapid, synchronized electrical bursts that cause seizures.
Scientists have studied Depakote extensively and still haven’t pinpointed one mechanism that fully explains its broad effectiveness. This “multiple targets” profile likely explains why it works across so many seizure types, but it also means the drug’s effects on the body are widespread, which contributes to its side effect profile.
Common Side Effects
The most frequently reported side effects are weight gain, tremor, and hair thinning. Weight changes can be significant enough to need medical attention in some people, particularly rapid or unexpected gains. Tremor, described as shakiness in the hands, arms, or legs, is one of the more common complaints and tends to be more pronounced in older adults, who may also experience unusual drowsiness. Hair loss or thinning is generally mild and often improves over time, though it can be distressing.
Nausea, drowsiness, and dizziness are also common, especially when first starting the medication. These side effects often ease as your body adjusts, but persistent or worsening symptoms are worth reporting to your prescriber.
Serious Safety Warnings
Depakote carries three major safety warnings that appear on its label in the strongest possible terms.
- Liver damage: Severe liver failure, sometimes fatal, has occurred in people taking Depakote. This risk is highest during the first six months of treatment. Children under two and people with mitochondrial disorders face the greatest danger.
- Pancreatitis: Life-threatening inflammation of the pancreas has been reported in both children and adults. Some cases progressed rapidly from the first symptoms to death. Severe abdominal pain, nausea, or vomiting while taking Depakote needs urgent evaluation.
- Harm during pregnancy: Depakote can cause serious birth defects, especially neural tube defects like spina bifida. It also affects a child’s brain development in lasting ways (more on this below).
Pregnancy and Cognitive Risks to Children
The risks of taking Depakote during pregnancy are among the most well-documented of any seizure medication. A study published in Neurology found that children exposed to high doses (above 800 mg daily) in the womb scored an average of 9.7 IQ points lower at age six compared to unexposed children. Those same children were eight times more likely to need special educational support in school.
Even at lower doses, the picture isn’t reassuring. Children exposed to less than 800 mg daily still showed impaired verbal abilities and were six times more likely to require educational intervention. By comparison, children exposed to other common seizure medications like lamotrigine and carbamazepine did not show these same deficits. For women of childbearing age, this risk is a central factor in choosing a seizure medication, and many doctors will try alternatives first.
Blood Level Monitoring
Depakote requires periodic blood tests to make sure the drug is at an effective level without being dangerously high. The target range for total valproic acid in the blood is 50 to 125 mcg/mL. Your doctor will also check liver function, especially in the early months of treatment, because of the liver damage risk. These blood draws are a routine part of being on Depakote and help your prescriber fine-tune your dose over time.
Interactions With Other Seizure Medications
If you take Depakote alongside other antiepileptic drugs, interactions can be significant. Depakote can push phenytoin off its binding sites in the blood, temporarily increasing the active amount of phenytoin in your system and potentially causing toxicity symptoms like dizziness, double vision, or unsteadiness. It also raises blood levels of lamotrigine, which can increase the risk of a serious skin reaction associated with that drug. When Depakote is added to or removed from a medication regimen, your other drug levels often need to be rechecked and doses adjusted.
These interactions don’t mean Depakote can’t be combined with other seizure medications. Combination therapy is common in epilepsy. But it does mean closer monitoring is needed, especially during transitions.